Inside This Issue  by unknown
NOVEMBER 29, 2011
VOLUME 58, NO. 23
JOURNAL of the AMERICAN COLLEGE of CARDIOLOGY
Inside This Issue
STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER2357Role of Chemokines in After Myocardial InfarctionElisa A. Liehn, Otilia Postea, Adelina Curaj, Nikolaus Marx
Despite extensive research, our current knowledge regarding the control of molecular and
cellular events after myocardial infarction is still limited. Chemokines and chemokine
receptors regulate leukocyte trafficking, angiogenesis, collagen synthesis, and cardiac repair.
Manipulating them by interfering with receptor–ligand interaction, chemokine–glycosaminoglycan
interaction, heteromerization, or other signaling pathways should enable us to control and
modify molecular and cellular events. This review by Liehn and colleagues highlights the
cellular and molecular processes after myocardial injury with a focus on the role of
chemokines.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY2363Initial Experience With Carotid Artery Stenting for Acute StrokePanagiotis Papanagiotou, Christian Roth, Silke Walter, Stefanie Behnke, Iris Grunwald, Julio Viera,
Maria Politi, Heiko Körner, Panagiotis Kostopoulos, Anton Haass, Klaus Fassbender, Wolfgang Reith
Papanagiotou and colleagues retrospectively analyzed 22 patients that were treated with
carotid artery stenting for extracranial internal carotid artery (ICA) lesions for acute stroke.
Patients who presented within 6 h of symptom onset were started on thrombolytic therapy
and then underwent angiography and stenting if the extracranial ICA was occluded, with
successful revascularization in 21 of 22 patients (95%). In 18 patients there was an additional
intracranial occlusion, most often in the middle cerebral artery, which was successfully treated
with restoration of Thrombolysis In Myocardial Infarction flow grade 2/3 in 11 of the 18
patients (61%). The angiographic and clinical results appear to be favorable compared with
prior experience with intravenous thrombolytic therapy, and further studies are planned.
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ECARDIOVASCULAR RISK2372Higher Fetuin-A Levels May Lower Cardiac RiskJoachim H. Ix, Elizabeth Barrett-Connor, Christina L. Wassel, Kevin Cummins, Jaclyn Bergstrom,
Lori B. Daniels, Gail A. Laughlin
Fetuin-A is a protein secreted from the liver that interacts with calcium and phosphorus,
increasing their solubility and inhibiting calcium crystal growth and precipitation. Ix and
colleagues measured fetuin-A levels from baseline samples in the Rancho Bernardo Study.
Fetuin-A levels were inversely associated with coronary artery calcification, and remained
significant in models adjusted for demographics, lifestyle factors, traditional cardiovascular
disease risk factors, and kidney function. In contrast, no association of fetuin-A was observed
with peripheral arterial disease or carotid intima-media thickness. These results may be useful
for exploring the pathogenesis of atherosclerosis and for use as a risk marker of cardiac
disease.HEART RHYTHM DISORDERS
2380CHA2DS2-VASc Score Is More Useful Than CHADS2
for Predicting Stroke Risk After Catheter Ablation of AFTze-Fan Chao, Yenn-Jiang Lin, Hsuan-Ming Tsao, Chin-Feng Tsai, Wei-Shiang Lin, Shih-Lin Chang,
Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Kazuyoshi Suenari, Cheng-Hung Li, Beny Hartono,
Hung-Yu Chang, Kibos Ambrose, Tsu-Juey Wu, Shih-Ann Chen
This study by Chao and colleagues tested whether CHADS2 and CHA2DS2-VASc scores are
useful for risk stratification in patients after catheter ablation of atrial fibrillation (AF). A total
of 565 patients with AF who underwent catheter ablation were followed for thromboembolic
events or death. Both the CHADS2 and CHA2DS2-VASc scores were useful for identifying
he 4.8% of patients with events, with a higher area under the curve for CHA2DS2-VASc.
The CHA2DS2-VASc score was able to further stratify the patients with CHADS2 scores of
0 or 1; those with a CHA2DS2-VASc score of 0 or 1 had an event rate of 1.1% compared
ith 7.1% in those with a score of 2 or higher. The CHA2DS2-VASc score appears to be
superior to the CHADS2 score for predicting adverse events after catheter ablation of AF.
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Victor Y. Cheng, Kavitha Chinnaiyan, Gil Raff, Todd C. Villines, Stephan Achenbach,
Matthew J. Budoff, Filippo Cademartiri, Tracy Q. Callister, Hyuk-Jae Chang, Augustin Delago,
Allison Dunning, Martin Hadamitzky, Jorg Hausleiter, Philipp Kaufmann, Fay Lin, Erica Maffei,
James K. Min, Leslee J. Shaw, Benjamin J. W. Chow
Small and colleagues reviewed data from almost 700 patients with previous coronary artery
bypass graft surgery (CABG) who underwent coronary computed tomography angiography
(CCTA). Patients were classified by unprotected coronary territory, or a summary of native
vessel disease and graft patency codified as the coronary artery protection score (CAPS). The
CAPS score, which ranges from 1 (single-vessel disease  1 protected territory) to 8 (3-vessel
disease  0 protected territories) was able to reliably classify patients for their subsequent risk
f death.HYPERTENSION2396Blood Pressure During College Linked to Future Cardiovascular DiseaseLinsay Gray, I-Min Lee, Howard D. Sesso, G. David Batty
Elevated blood pressure in middle-age is an established cardiovascular disease risk factor,
but evidence for association with measurements earlier in life is sparse. Gray and colleagues
reviewed data from a cohort study of 18,881 male university students who had blood pressure
measured at a mean age of 18 years and who responded to a questionnaire mailed when their
mean age was 46 years. Following adjustment for age, body mass index, smoking, and
physical activity at college entry, there was an incremental increase in cardiovascular mortality
from normotensive (120/80 mm Hg), through pre-hypertensive, stage 1, and stage 2
blood pressure measurements. Higher blood pressure in early adulthood is associated with
elevated risk of mortality later in life.
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2406Risk of Early Death in Patients With HCM:
A Multigenerational, Natural History AnalysisEline A. Nannenberg, Michelle Michels, Imke Christiaans, Danielle Majoor-Krakauer,
Yvonne M. Hoedemaekers, J. Peter van Tintelen, M. Paola Lombardi, Folkert J. ten Cate,
Arend F. L. Schinkel, Jan G.P. Tijssen, Irene M. van Langen, Arthur A. M. Wilde, Eric J. G. Sijbrands
Hypertrophic cardiomyopathy (HCM) increases the risk of sudden cardiac death, but the
natural history of the disorder in untreated populations is not well defined. Nannenberg and
colleagues used data from genealogical searches to identify 6 large 200-year multigenerational
pedigrees and 140 smaller, contemporary pedigrees who were first-degree relatives of a
proband. All pedigrees contained members with HCM caused by a truncating mutation in
the myosin-binding protein C (MYBPC3) gene. In the large pedigrees, overall mortality was
not increased, but significant excess mortality occurred between ages 10 and 19 years. In the
small families, the standardized mortality ratio was increased in most age groupings. The
reason for the different outcomes is not clear, but the authors speculate that the contemporary
families harbored a more lethal phenotype that provoked a clinical evaluation.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH2415Blocking Cxcr4 Pathway Reduces Infarct Size, Inhibits AngiogenesisElisa A. Liehn, Nancy Tuchscheerer, Isabella Kanzler, Maik Drechsler, Line Fraemohs, Alexander Schuh,
Robert R. Koenen, Simone Zandler, Oliver Soehnlein, Mihail Hristov, Gabriela Grigorescu, Andreea O. Urs,
Mircea Leabu, Ilie Bucur, Marc W. Merx, Alma Zernecke, Josef Ehling, Felix Gremse, Twan Lammers,
Fabian Kiessling, Jürgen Bernhagen, Andreas Schober, Christian Weber
The Cxcr4 receptor ligand CXCL12 has been implicated in protection and regeneration after
myocardial infarction (MI), but its role is not fully understood. Liehn and colleagues studied
Cxcr4-heterozygous (Cxcr4/) mice by ligation of the left descending artery. After 4 weeks,
nfarct size was reduced in Cxcr4/ mice, with diminished neutrophil content and delayed
monocyte infiltration. However, Langendorff perfusion showed that basal coronary flow and
its recovery after MI were significantly impaired in Cxcr4/ mice and that these mice also
had reduced angiogenesis and lower myocardial vessel density. These results confirm that
Cxcr4 plays a crucial role in endogenous remodeling processes after MI, but the full effects
need to be more thoroughly studied before clinical use.Editorial Comment: Nikolaos G. Frangogiannis, p. 2424
